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INTRODUCTION
•

Antibiotic resistance has become a global healthcare crisis
(CDC, 2016b).
•

When antibiotics are taken, sensitive bacteria are
killed while resistant bacteria grow and flourish
(CDC, 2016b).

• The more often antibiotics are taken, the greater
the ability for resistant bacteria to grow; leading to
an increase in drug-resistant organisms (CDC,
2017).
•

•

•

2 million people are infected by resistant bacteria each year
in the U.S and about 23,000 people die of their infections
(CDC, 2017).
Antibiotic resistance poses a risk to advances in medicine,
such as organ transplantation and chemotherapy treatment,
because there are less antibiotics to treat
immunocompromised patients who develop an infection
caused by a drug resistant organism (WHO, 2018).
Antibiotic resistance, if not properly dealt with, can bring the
world to a post-antibiotic era where simple infections will
once again be life-threatening (WHO, 2018).

BACKGROUND
•

•

Thirty percent of antibiotic prescribed in the out-patient
setting are unnecessary and inappropriately prescribed
(CDC, 2016b).

CRITICAL APPRAISALS
RCT (Level II Evidence) Gjelstad et al. (2013)
•

•

Over 90% of patients who present with a cough and are
diagnosed with acute bronchitis have an infection caused by
a virus (Harris, Hicks & Qaseem, 2016).

•

Providers have a responsibility to keep up to date with
current antibiotic practice guidelines and to educate patients
accordingly.
• Providers can help curb the growing healthcare
crisis of antibiotic resistance by prescribing
antibiotics only when necessary.

Intervention
Intervention group- educational program regarding current
treatment guidelines for upper respiratory infections
presented by peer academic detailers.

•

Control group- education regarding appropriate drug
treatment in patients > 70 years old presented by peer
academic detailers.

•

Retrospective data was collected at the start and one year
after the completion of the intervention.

SEARCH METHODOLOGY
•

Databases: CINAHL, MEDLINE & PubMed

•

Keywords: antibiotics, upper respiratory tract infection, acute
bronchitis, continuing education & antibiotic stewardship

•

The PICOT question was support by one randomized
controlled trial, one systematic review and one clinical
practice guideline.

Risks:
• Provider fears (Harris et al., 2016):
• Decrease in patient satisfaction rates
• Legal action
• Diagnostic uncertainty
• Secondary bacterial infection

APPLICABILITY FOR CHANGE
IN PRACTICE

Results
•

Reduction in the number of antibiotic prescriptions issued for
upper respiratory infections with a 95% CI.
• Reduction in antibiotic prescriptions issued for
acute bronchitis with a P value < 0.01.

SR (Level I Evidence) Kochling et al. (2018)

•

Implementing this evidence-based practice project in
practice will benefit the provider, patient and the global
healthcare community.

•

Critical appraisal of the current literature has shown that
provider education is instrumental in reducing antibiotic
prescriptions for acute bronchitis.

•

The antibiotic stewardship program provided by the CDC is
easily accessible, free and available to the public.

•

This EBPP, which is in line with current practice guidelines,
can assist in creating a positive change to providers’ practice
for acute bronchitis making this EBPP highly applicable and
recommended for the APN in the primary care setting.

Objective
•

Review the current evidence and summarize the
effectiveness of interventions used to reduce the number of
antibiotics prescribed for upper respiratory infections in the
primary care setting.

Intervention
•

Compared 17 RCTs that used one or more of the following
interventions: educational seminars, feedback on prescribing
habits, patient education, communication skills training for
providers and diagnostic tools.

Results
•

•

PICOT QUESTION
Among primary care providers treating adults in a primary
care setting, does a web-based educational program aimed
at appropriate antibiotic prescribing decrease the number of
inappropriate antibiotic prescriptions issued during the
initial visit to low risk adults diagnosed with uncomplicated
acute bronchitis, over a 3-month period?

Determine the effects of an educational program for general
practitioners in reducing the number of inappropriate
antibiotics prescribed to patients diagnosed with upper
respiratory infections.

•

BENEFITS AND RISKS
Benefits:
• Reduction in the number of drug resistant organisms (CDC,
2016b).
• Reduction in the number of adverse events caused by
antibiotics (Harris et al., 2016).
• A $6.5 million direct reduction and $30 billion indirect
reduction to the U.S. economy per year (Harris et al., 2016).

Objective

Acute upper respiratory tract infections are the leading
cause of inappropriate antibiotic prescriptions (CDC, 2016b).
• Acute bronchitis tops all upper respiratory tract
infections in this regard (CDC, 2016b).

ALGORITHM

Interventions that target providers rather then patients were
more successful in reducing antibiotic prescription rates for
upper respiratory infections.
Interventions that target providers via an educational program
regarding antibiotic prescription guidelines for upper
respiratory infections showed a statistically significant
change.
• These interventions did not meet the researchers’
definition of a clinically relevant reduction with an
absolute reduction rate of 10%.

Guideline (Level I Evidence) Harris et al. (2016)
Objective
•

To provide best practice guidelines for prescribing antibiotics
to healthy adult patients diagnosed with acute upper
respiratory tract infections.

Recommendation
•

Antibiotics should not be prescribed for acute bronchitis
unless pneumonia is suspected.
• Symptomatic treatment may be prescribed.

•

In a patient who presents with a cough, no further testing is
warranted unless tachycardia, tachypnea, fever and/or
abnormal findings on chest examination are present.

THEORETICAL FRAMEWORK
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